SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-18-000822
Filing Date
2018-02-01
Accepted
2018-02-01 16:00:13
Documents
3
Period of Report
2018-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_020118.htm 8-K 21555
2 EXHIBIT 10.1 exh_101.htm EX-10.1 18000
3 EXHIBIT 10.2 exh_102.htm EX-10.2 65796
  Complete submission text file 0001171843-18-000822.txt   106719
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 18566856
SIC: 2834 Pharmaceutical Preparations